556.0000 -4.05 (-0.72%)
NSE Dec 29, 2025 15:31 PM
Volume: 50,360
 

556.00
-0.72%
Axis Direct
We expect the whole API industry to continue facing challenges due to a fall in realization as well as an increase in cost pressure. We foresee the situation to continue for the next 2-3 quarters and therefore recommend a HOLD rating on the stock with the target price of Rs 1,300/share.
Promoters unpledged 3.63% of shares in last quarter. Total pledge stands at 35.32% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended